Similar articles for PMID: 21849186

Year	Number of Results
1939	1
1947	2
1958	1
1987	1
1992	1
1996	1
1997	1
1999	2
2000	1
2001	4
2002	5
2003	5
2004	13
2005	7
2006	9
2007	15
2008	6
2009	7
2010	14
2011	17
2012	14
2013	11
2014	8
2015	5
2016	5
2017	6
2018	2
2019	4
2020	5
2021	1
2022	2
2024	0

1

Dutasteride reduces prostatitis symptoms compared with placebo in men enrolled in the REDUCE study.

Nickel JC, Roehrborn C, Montorsi F, Wilson TH, Rittmaster RS. Nickel JC, et al. J Urol. 2011 Oct;186(4):1313-8. doi: 10.1016/j.juro.2011.05.071. Epub 2011 Aug 17. J Urol. 2011. PMID: 21849186 Clinical Trial.

2

Examination of the relationship between symptoms of prostatitis and histological inflammation: baseline data from the REDUCE chemoprevention trial.

Nickel JC, Roehrborn CG, O'leary MP, Bostwick DG, Somerville MC, Rittmaster RS. Nickel JC, et al. J Urol. 2007 Sep;178(3 Pt 1):896-900; discussion 900-1. doi: 10.1016/j.juro.2007.05.041. Epub 2007 Jul 16. J Urol. 2007. PMID: 17632164

3

Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind Combination of Avodart and Tamsulosin (CombAT) trial.

Roehrborn CG, Barkin J, Siami P, Tubaro A, Wilson TH, Morrill BB, Gagnier RP. Roehrborn CG, et al. BJU Int. 2011 Mar;107(6):946-54. doi: 10.1111/j.1464-410X.2011.10124.x. Epub 2011 Feb 18. BJU Int. 2011. PMID: 21332630 Clinical Trial.

4

Dutasteride improves outcomes of benign prostatic hyperplasia when evaluated for prostate cancer risk reduction: secondary analysis of the REduction by DUtasteride of prostate Cancer Events (REDUCE) trial.

Roehrborn CG, Nickel JC, Andriole GL, Gagnier RP, Black L, Wilson TH, Rittmaster RS. Roehrborn CG, et al. Urology. 2011 Sep;78(3):641-6. doi: 10.1016/j.urology.2011.03.063. Epub 2011 Jul 20. Urology. 2011. PMID: 21764428 Clinical Trial.

5

Silodosin for men with chronic prostatitis/chronic pelvic pain syndrome: results of a phase II multicenter, double-blind, placebo controlled study.

Nickel JC, O'Leary MP, Lepor H, Caramelli KE, Thomas H, Hill LA, Hoel GE. Nickel JC, et al. J Urol. 2011 Jul;186(1):125-31. doi: 10.1016/j.juro.2011.03.028. Epub 2011 May 14. J Urol. 2011. PMID: 21571345 Clinical Trial.

6

The effect of dutasteride on the peripheral and transition zones of the prostate and the value of the transition zone index in predicting treatment response.

Marks LS, Roehrborn CG, Wolford E, Wilson TH. Marks LS, et al. J Urol. 2007 Apr;177(4):1408-13. doi: 10.1016/j.juro.2006.11.095. J Urol. 2007. PMID: 17382742 Clinical Trial.

7

Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index.

Nickel JC, Downey J, Hunter D, Clark J. Nickel JC, et al. J Urol. 2001 Mar;165(3):842-5. J Urol. 2001. PMID: 11176483

8

Effect of dutasteride, tamsulosin and the combination on patient-reported quality of life and treatment satisfaction in men with moderate-to-severe benign prostatic hyperplasia: 4-year data from the CombAT study.

Montorsi F, Henkel T, Geboers A, Mirone V, Arrosagaray P, Morrill B, Black L. Montorsi F, et al. Int J Clin Pract. 2010 Jul;64(8):1042-51. doi: 10.1111/j.1742-1241.2010.02428.x. Epub 2010 May 7. Int J Clin Pract. 2010. PMID: 20487046 Clinical Trial.

9

A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis.

Nickel JC, Pontari M, Moon T, Gittelman M, Malek G, Farrington J, Pearson J, Krupa D, Bach M, Drisko J; Rofecoxib Prostatitis Investigator Team. Nickel JC, et al. J Urol. 2003 Apr;169(4):1401-5. doi: 10.1097/01.ju.0000054983.45096.16. J Urol. 2003. PMID: 12629372 Clinical Trial.

10

Symptoms suggestive of chronic pelvic pain syndrome in an urban population: prevalence and associations with lower urinary tract symptoms and erectile function.

Marszalek M, Wehrberger C, Hochreiter W, Temml C, Madersbacher S. Marszalek M, et al. J Urol. 2007 May;177(5):1815-9. doi: 10.1016/j.juro.2007.01.008. J Urol. 2007. PMID: 17437827

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

157 results

Results by year